Vertex Pharmaceuticals has received a “Moderate Buy” consensus from 29 brokerages, with most analysts either holding or ...

In an era of rising complexity, rapid technology shifts, budget pressures, and uninsurable risks, traditional security approaches no longer suffice. Businesses need to understand where they're ...

Analysts remain bullish on Vertex Pharmaceuticals as HC Wainwright reaffirmed its buy rating with a $550 price target.

This was the stock's second consecutive day of gains.

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Web Services is working on revamping its artificial intelligence cloud service, Bedrock, in an effort to make it easier for ...

Vertex Announces First Quarter 2025 Financial Results. KING OF PRUSSIA, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global ...

Services PMI® at 49.9%; ... Its community of more than 50,000 in more than 100 countries around the world manage about US$1 trillion in corporate and government supply chain procurement annually.

Quess Corp has launched Origint, a new business line targeting the growing Global Capability Centre (GCC) market. This single-window solution aims to streamline GCC setup in India, offering services ...

The Vertex buy follows Tasmea’s $84.5 million acquisition of WA-based Future Engineering Group in August 2024, and Tasmea shares were up 7.24 per cent in midday trade, priced at $3.11 per share in a ...